274 related articles for article (PubMed ID: 29278616)
1. Decreased Acute Otitis Media With Treatment Failure After Introduction of the Ten-valent Pneumococcal Haemophilus influenzae Protein D Conjugate Vaccine.
Eythorsson E; Hrafnkelsson B; Erlendsdóttir H; Gudmundsson SA; Kristinsson KG; Haraldsson Á
Pediatr Infect Dis J; 2018 Apr; 37(4):361-366. PubMed ID: 29278616
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial.
Sáez-Llorens X; Rowley S; Wong D; Rodríguez M; Calvo A; Troitiño M; Salas A; Vega V; Castrejón MM; Lommel P; Pascal TG; Hausdorff WP; Borys D; Ruiz-Guiñazú J; Ortega-Barría E; Yarzabal JP; Schuerman L
Hum Vaccin Immunother; 2017 Jun; 13(6):1-16. PubMed ID: 28368738
[TBL] [Abstract][Full Text] [Related]
3. Reduction in All-Cause Acute Otitis Media in Children <3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study.
Sigurdsson S; Eythorsson E; Hrafnkelsson B; Erlendsdóttir H; Kristinsson KG; Haraldsson Á
Clin Infect Dis; 2018 Sep; 67(8):1213-1219. PubMed ID: 29617959
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial.
Tregnaghi MW; Sáez-Llorens X; López P; Abate H; Smith E; Pósleman A; Calvo A; Wong D; Cortes-Barbosa C; Ceballos A; Tregnaghi M; Sierra A; Rodriguez M; Troitiño M; Carabajal C; Falaschi A; Leandro A; Castrejón MM; Lepetic A; Lommel P; Hausdorff WP; Borys D; Ruiz Guiñazú J; Ortega-Barría E; Yarzábal JP; Schuerman L;
PLoS Med; 2014 Jun; 11(6):e1001657. PubMed ID: 24892763
[TBL] [Abstract][Full Text] [Related]
5. Effect of pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) on outpatient antimicrobial purchases: a double-blind, cluster randomised phase 3-4 trial.
Palmu AA; Jokinen J; Nieminen H; Rinta-Kokko H; Ruokokoski E; Puumalainen T; Borys D; Lommel P; Traskine M; Moreira M; Schuerman L; Kilpi TM
Lancet Infect Dis; 2014 Mar; 14(3):205-12. PubMed ID: 24287186
[TBL] [Abstract][Full Text] [Related]
6. Prevention of otitis media: now a reality?
Schuerman L; Borys D; Hoet B; Forsgren A; Prymula R
Vaccine; 2009 Sep; 27(42):5748-54. PubMed ID: 19666154
[TBL] [Abstract][Full Text] [Related]
7. Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.
Prymula R; Kriz P; Kaliskova E; Pascal T; Poolman J; Schuerman L
Vaccine; 2009 Dec; 28(1):71-8. PubMed ID: 19818722
[TBL] [Abstract][Full Text] [Related]
8. Impact of protein D-containing pneumococcal conjugate vaccines on non-typeable Haemophilus influenzae acute otitis media and carriage.
Clarke C; Bakaletz LO; Ruiz-Guiñazú J; Borys D; Mrkvan T
Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28571504
[TBL] [Abstract][Full Text] [Related]
9. The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland.
Sveinsdóttir H; Björnsdóttir JB; Erlendsdóttir H; Hjálmarsdóttir MÁ; Hrafnkelsson B; Haraldsson Á; Kristinsson KG; Haraldsson G
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31068412
[TBL] [Abstract][Full Text] [Related]
10. Acute otitis media in infants younger than two months of age: Epidemiologic and microbiologic characteristics in the era of pneumococcal conjugate vaccines.
Ziv O; Kraus M; Holcberg R; Dinur AB; Kordeluk S; Kaplan D; Rosenblatt HN; Ben-Shimol S; Greenberg D; Leibovitz E
Int J Pediatr Otorhinolaryngol; 2019 Apr; 119():123-130. PubMed ID: 30703661
[TBL] [Abstract][Full Text] [Related]
11. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial.
Kilpi TM; Jokinen J; Puumalainen T; Nieminen H; Ruokokoski E; Rinta-Kokko H; Traskine M; Lommel P; Moreira M; Ruiz-Guinazu J; Borys D; Schuerman L; Palmu AA
Vaccine; 2018 Sep; 36(39):5891-5901. PubMed ID: 30145098
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
[TBL] [Abstract][Full Text] [Related]
14. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
De Wals P; Black S; Borrow R; Pearce D
Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.
Ruiz-Palacios GM; Guerrero ML; Hernández-Delgado L; Lavalle-Villalobos A; Casas-Muñoz A; Cervantes-Apolinar Y; Moreira M; Schuerman L
Hum Vaccin; 2011 Nov; 7(11):1137-45. PubMed ID: 22048109
[TBL] [Abstract][Full Text] [Related]
16. [Acute otitis media in the era of pneumococcal vaccination].
Baquero-Artigao F; del Castillo F
Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):505-9. PubMed ID: 19094865
[TBL] [Abstract][Full Text] [Related]
17. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
Forsgren A; Riesbeck K; Janson H
Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
Vesikari T; Forsten A; Seppä I; Kaijalainen T; Puumalainen T; Soininen A; Traskine M; Lommel P; Schoonbroodt S; Hezareh M; Moreira M; Borys D; Schuerman L
J Pediatric Infect Dis Soc; 2016 Sep; 5(3):237-248. PubMed ID: 27125273
[TBL] [Abstract][Full Text] [Related]
19. New vaccines against otitis media: projected benefits and cost-effectiveness.
O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
[TBL] [Abstract][Full Text] [Related]
20. Increase in Haemophilus influenzae Detection in 13-Valent Pneumococcal Conjugate Vaccine Immunized Children With Acute Otitis Media.
Klein A; Tamir SO; Sorek N; Hanun G; Yeshayahu Y; Marom T
Pediatr Infect Dis J; 2022 Aug; 41(8):678-680. PubMed ID: 35436266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
